These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25961960)

  • 21. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.
    Savarino A
    Retrovirology; 2007 Mar; 4():21. PubMed ID: 17374162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
    Li X; Vince R
    Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.
    Sharma H; Sanchez TW; Neamati N; Detorio M; Schinazi RF; Cheng X; Buolamwini JK
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6146-51. PubMed ID: 24091080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase.
    Li X; Vince R
    Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.
    Nair V; Chi G; Ptak R; Neamati N
    J Med Chem; 2006 Jan; 49(2):445-7. PubMed ID: 16420027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors.
    Esposito F; Sechi M; Pala N; Sanna A; Koneru PC; Kvaratskhelia M; Naesens L; Corona A; Grandi N; di Santo R; D'Amore VM; Di Leva FS; Novellino E; Cosconati S; Tramontano E
    Antiviral Res; 2020 Feb; 174():104671. PubMed ID: 31812637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation.
    De Luca L; De Grazia S; Ferro S; Gitto R; Christ F; Debyser Z; Chimirri A
    Eur J Med Chem; 2011 Feb; 46(2):756-64. PubMed ID: 21227550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
    Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
    Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
    Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
    J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
    Wu B; Tang J; Wilson DJ; Huber AD; Casey MC; Ji J; Kankanala J; Xie J; Sarafianos SG; Wang Z
    J Med Chem; 2016 Jul; 59(13):6136-48. PubMed ID: 27283261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of novel hybrid dicaffeoyltartaric/diketo acid and tetrazole-substituted L-chicoric acid analogue inhibitors of human immunodeficiency virus type 1 integrase.
    Crosby DC; Lei X; Gibbs CG; McDougall BR; Robinson WE; Reinecke MG
    J Med Chem; 2010 Nov; 53(22):8161-75. PubMed ID: 20977258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds].
    Yu SH; Tan YM; Zhao GS
    Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
    Dayam R; Sanchez T; Neamati N
    J Med Chem; 2005 Dec; 48(25):8009-15. PubMed ID: 16335925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
    Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notable difference in anti-HIV activity of integrase inhibitors as a consequence of geometric and enantiomeric configurations.
    Okello M; Mishra S; Nishonov M; Nair V
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4112-6. PubMed ID: 23746474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.